Study compares three drug approaches for rare childhood inflammatory syndrome

Researchers analyzed which treatments work best for multisystem inflammatory syndrome in children, comparing immunoglobulin therapy, steroids, and combination approaches. The findings could help clinicians standardize care for this serious post-viral condition and reduce hospital costs and patient complications.

Originaltitel: Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study